<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cureus</journal-id><journal-id journal-id-type="iso-abbrev">Cureus</journal-id><journal-id journal-id-type="pmc-domain-id">2757</journal-id><journal-id journal-id-type="pmc-domain">cureus</journal-id><journal-title-group><journal-title>Cureus</journal-title></journal-title-group><issn pub-type="epub">2168-8184</issn><publisher><publisher-name>Cureus Inc.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11494027</article-id><article-id pub-id-type="pmcid-ver">PMC11494027.1</article-id><article-id pub-id-type="pmcaid">11494027</article-id><article-id pub-id-type="pmcaiid">11494027</article-id><article-id pub-id-type="pmid">39439610</article-id><article-id pub-id-type="doi">10.7759/cureus.69880</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Internal Medicine</subject></subj-group><subj-group><subject>Medical Education</subject></subj-group><subj-group><subject>Medical Simulation</subject></subj-group></article-categories><title-group><article-title>Role of Adjuvants in Enhancing the Efficacy and Duration of Anesthesia Blocks: A Comprehensive Review</article-title></title-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Muacevic</surname><given-names initials="A">Alexander</given-names></name></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Adler</surname><given-names initials="JR">John R</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Singhal</surname><given-names initials="A">Akansha</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Taksande</surname><given-names initials="K">Karuna</given-names></name><xref rid="aff-1" ref-type="aff">1</xref></contrib></contrib-group><aff id="aff-1">
<label>1</label>
Anesthesiology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND </aff><author-notes><corresp id="cor1">
Akansha Singhal <email>singhal.akansha17@gmail.com</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>9</month><year>2024</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>9</month><year>2024</year></pub-date><volume>16</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">469782</issue-id><elocation-id>e69880</elocation-id><history><date date-type="received"><day>9</day><month>9</month><year>2024</year></date><date date-type="accepted"><day>21</day><month>9</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>21</day><month>09</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>22</day><month>10</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-23 09:25:16.937"><day>23</day><month>10</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2024, Singhal et al.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Singhal et al.</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="cureus-0016-00000069880.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cureus.com/articles/299181-role-of-adjuvants-in-enhancing-the-efficacy-and-duration-of-anesthesia-blocks-a-comprehensive-review">This article is available from https://www.cureus.com/articles/299181-role-of-adjuvants-in-enhancing-the-efficacy-and-duration-of-anesthesia-blocks-a-comprehensive-review</self-uri><abstract><p>Anesthesia blocks are integral to modern pain management, offering targeted and effective relief for various surgical and procedural interventions. These techniques, including regional and peripheral nerve blocks (PNBs), involve the administration of local anesthetics to specific body areas, either through epidural, spinal, or direct nerve injections. While effective, incorporating adjuvants, substances added to local anesthetics, can significantly enhance their efficacy and prolong their duration. Adjuvants such as opioids, corticosteroids, alpha-2 agonists, and nonsteroidal anti-inflammatory drugs (NSAIDs) are used to amplify analgesic effects, reduce the need for general anesthesia, and improve postoperative outcomes. This review explores the role of adjuvants in optimizing anesthesia blocks, examining their mechanisms of action, clinical benefits, and safety considerations. Adding adjuvants can lead to enhanced pain control, reduced dosage of local anesthetics, and fewer systemic side effects. By integrating adjuvants into anesthesia practice, clinicians can achieve more precise and sustained pain management, tailoring approaches to individual patient needs and specific procedural demands. This comprehensive review highlights current evidence on using adjuvants, their impact on anesthesia block effectiveness, and future research directions. Understanding the role of adjuvants is crucial for improving patient outcomes and advancing pain management techniques in various surgical settings.</p></abstract><kwd-group kwd-group-type="author"><kwd>adjuvants</kwd><kwd>anesthesia blocks</kwd><kwd>local anesthetics</kwd><kwd>pain management</kwd><kwd>peripheral nerve blocks</kwd><kwd>regional anesthesia</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction and background</title><p>Anesthesia blocks are a fundamental aspect of modern anesthesia practice, offering targeted pain relief for various surgical and procedural interventions [<xref rid="REF1" ref-type="bibr">1</xref>]. These techniques involve the administration of local anesthetics to specific regions of the body to achieve effective analgesia, either by blocking sensory nerves or interrupting pain signal transmission to the central nervous system [<xref rid="REF2" ref-type="bibr">2</xref>]. Regional blocks, for instance, include methods such as epidural and spinal anesthesia, which involve injecting anesthetics into areas around the spinal cord to cover larger areas of the body. On the other hand, peripheral nerve blocks (PNBs) target individual nerves or nerve bundles to provide pain relief to specific limbs or regions, such as the femoral nerve block used for knee surgeries or the sciatic nerve block for foot and ankle procedures [<xref rid="REF3" ref-type="bibr">3</xref>]. The clinical significance of anesthesia blocks extends beyond mere pain management. They are commonly employed to reduce the necessity for general anesthesia, which can help minimize systemic side effects and shorten recovery times [<xref rid="REF4" ref-type="bibr">4</xref>]. This targeted approach improves patient comfort during and after surgery and contributes to quicker postoperative recovery and reduced incidence of postoperative nausea. By effectively controlling pain and potentially enhancing patient outcomes, anesthesia blocks play a crucial role in various surgical disciplines, including orthopedics, obstetrics, and abdominal surgery [<xref rid="REF5" ref-type="bibr">5</xref>].</p><p>Integrating adjuvants into anesthesia practice has significantly advanced the field by enhancing the efficacy and duration of anesthesia blocks. Adjuvants are substances added to local anesthetics to augment their effects, either by increasing the level of analgesia or by extending the duration of pain relief [<xref rid="REF6" ref-type="bibr">6</xref>]. Their purpose is multifaceted: they can enhance the potency of local anesthetics, prolong the duration of analgesia, and improve overall pain management. By modulating pain pathways or working synergistically with local anesthetics, adjuvants help achieve more effective and sustained pain control [<xref rid="REF6" ref-type="bibr">6</xref>]. In clinical practice, the role of adjuvants is pivotal in optimizing anesthesia techniques. Their use allows anesthesiologists to fine-tune pain relief strategies, potentially reducing the need for higher doses of local anesthetics and minimizing the risk of adverse effects [<xref rid="REF6" ref-type="bibr">6</xref>]. By carefully selecting and administering adjuvants, healthcare providers can tailor anesthesia management to individual patient needs, improving the effectiveness of anesthesia blocks and the overall patient experience. This refined approach underscores the importance of understanding and leveraging adjuvants to enhance anesthesia outcomes and advance pain management practices [<xref rid="REF7" ref-type="bibr">7</xref>].</p></sec><sec sec-type="review"><title>Review</title><p>Mechanism of action of anesthesia adjuvants</p><p>Anesthesia adjuvants play a pivotal role in enhancing the effectiveness of local anesthetics through various pharmacodynamic and pharmacokinetic interactions. These agents can impact the solubility and absorption of local anesthetics, resulting in a faster onset and extended duration of action [<xref rid="REF7" ref-type="bibr">7</xref>]. For example, certain adjuvants can increase the solubility of local anesthetics, facilitating quicker absorption into target tissues. Additionally, vasoconstrictors like epinephrine are commonly used as adjuvants; they induce localized vasoconstriction, decreasing the local anesthetic's systemic absorption [<xref rid="REF7" ref-type="bibr">7</xref>]. This not only prolongs the duration of anesthesia but also reduces the risk of systemic toxicity. Furthermore, many adjuvants exhibit synergistic analgesic effects when combined with local anesthetics, enhancing the quality and intensity of anesthesia [<xref rid="REF7" ref-type="bibr">7</xref>]. Various types of adjuvants are used with local anesthetics, each offering distinct mechanisms of action and benefits. Opioids, such as morphine and fentanyl, are frequently employed to enhance analgesia. They act on mu-opioid receptors in the central nervous system, relieving pain. However, their use may be limited by side effects, including respiratory depression, nausea, vomiting, and pruritus, which require careful management [<xref rid="REF8" ref-type="bibr">8</xref>]. Corticosteroids, particularly dexamethasone, have gained popularity for their ability to reduce inflammation and prolong analgesia. When administered perineurally, corticosteroids are more effective than systemic administration in extending the duration of pain relief, making them valuable in managing postoperative pain and other inflammatory conditions [<xref rid="REF9" ref-type="bibr">9</xref>]. Alpha-2 agonists, such as clonidine and dexmedetomidine, are another class of adjuvants that enhance sedation and analgesia. These agents inhibit norepinephrine release, leading to a prolonged duration of sensory and motor blocks, significantly improving patient comfort during and after surgical procedures [<xref rid="REF10" ref-type="bibr">10</xref>]. Nonsteroidal anti-inflammatory drugs (NSAIDs) are also employed as adjuvants because they reduce inflammation and pain by inhibiting the synthesis of prostaglandins. They are particularly effective in multimodal analgesia strategies, offering additional pain relief alongside local anesthetics [<xref rid="REF11" ref-type="bibr">11</xref>]. Finally, other adjuvants, such as bicarbonate and vasoconstrictors, play important roles in anesthesia management. Adding bicarbonate to local anesthetics can increase the pH, enhance drug ionization, and lead to a faster onset of action. Vasoconstrictors, like epinephrine, extend the duration of anesthesia and help minimize systemic absorption, thereby reducing the risk of toxicity [<xref rid="REF12" ref-type="bibr">12</xref>].</p><p>Clinical evidence on efficacy and duration</p><p>Effectiveness of Common Adjuvants</p><p>Numerous studies and meta-analyses have explored the role of various adjuvants in enhancing the effects of local anesthetics. Among the most extensively studied is dexamethasone, a corticosteroid renowned for its anti-inflammatory properties [<xref rid="REF7" ref-type="bibr">7</xref>,<xref rid="REF13" ref-type="bibr">13</xref>]. Research indicates that dexamethasone can significantly extend the duration of analgesia in PNBs, with some studies reporting an increase in analgesic effects by up to 50% compared to local anesthetics used alone. This makes dexamethasone a valuable addition to regional anesthesia protocols, especially for patients undergoing procedures associated with inflammatory pain [<xref rid="REF14" ref-type="bibr">14</xref>,<xref rid="REF15" ref-type="bibr">15</xref>]. Another prominent adjuvant is clonidine, an alpha-2 adrenergic agonist. Clonidine has been shown to enhance the duration of sensory and motor blocks, with meta-analyses indicating an average increase in analgesia duration of approximately 30-40%. Its dual action-providing sedation while prolonging analgesia makes it particularly appealing for use in regional anesthesia. Similarly, dexmedetomidine, a more selective alpha-2 agonist, has gained attention for its ability to extend analgesia while maintaining a favorable safety profile. Studies suggest that dexmedetomidine can enhance the quality of anesthesia and prolong sensory block duration without significant adverse effects [<xref rid="REF16" ref-type="bibr">16</xref>-<xref rid="REF18" ref-type="bibr">18</xref>]. Magnesium has also emerged as a noteworthy adjuvant in anesthesia. As an NMDA receptor antagonist, magnesium can potentially reduce central sensitization, a key factor in the development of chronic pain. While the efficacy of magnesium as an adjuvant is still being explored, some studies suggest that it can contribute to prolonged analgesia when used alongside local anesthetics [<xref rid="REF19" ref-type="bibr">19</xref>]. When comparing the efficacy of these adjuvants, it becomes clear that while all enhance analgesic effects, their effectiveness varies significantly. Dexamethasone is often regarded as one of the most effective adjuvants for prolonging nerve block duration, particularly in inflammatory settings. In contrast, clonidine and dexmedetomidine are favored for their sedative properties, making them ideal for more complex regional anesthesia scenarios. However, magnesium shows promise but is less frequently utilized than other adjuvants due to the variability in outcomes reported across different studies [<xref rid="REF13" ref-type="bibr">13</xref>].</p><p>Duration of Anesthesia</p><p>The impact of adjuvants on extending the duration of anesthesia blocks has been a major focus of clinical research. The incorporation of adjuvants has consistently proven to significantly prolong anesthesia block effectiveness. For instance, research indicates that dexamethasone can extend nerve block duration by several hours, substantially reducing the need for rescue analgesia during the postoperative period. This extension enhances patient comfort and contributes to a more favorable recovery experience [<xref rid="REF20" ref-type="bibr">20</xref>]. Similarly, the use of clonidine and dexmedetomidine has been associated with extended sensory and motor block durations. Clinical trials have reported increases in the duration of action by 50% or more when these adjuvants are combined with local anesthetics. These findings highlight the importance of selecting appropriate adjuvants to optimize analgesic outcomes for patients undergoing surgical procedures [<xref rid="REF21" ref-type="bibr">21</xref>]. Numerous case studies and clinical trials further support the efficacy of these adjuvants. For example, a clinical trial involving dexamethasone in brachial plexus blocks demonstrated a significant increase in analgesia duration, with patients experiencing lower pain scores and longer intervals before needing additional analgesics. Similarly, studies involving clonidine and dexmedetomidine have shown that patients benefit from prolonged pain relief and reduced opioid consumption postoperatively, underscoring the role of these adjuvants in multimodal analgesia strategies [<xref rid="REF22" ref-type="bibr">22</xref>].</p><p>Safety and side effects</p><p>Using adjuvants in combination with local anesthetics can lead to various adverse effects. Common side effects include local reactions such as pain, swelling, or erythema at the injection site and systemic reactions like fever, malaise, or fatigue, which are generally mild and transient [<xref rid="REF7" ref-type="bibr">7</xref>]. Rare but serious side effects may include neurotoxicity, potentially resulting in nerve injury; however, this is infrequent and usually associated with specific adjuvants or high concentrations. Allergic reactions, including anaphylaxis or other hypersensitivity reactions, can occur, though rare. Some adjuvants have also been linked to a risk of developing autoimmune disorders, though definitive causation remains unclear [<xref rid="REF7" ref-type="bibr">7</xref>]. Certain patient populations may be at higher risk for adverse effects from adjuvants. Immunocompromised individuals, those with weakened immune systems, may experience different reactions. Patients with a history of allergies to medications or vaccines may be more susceptible to adverse effects. Older adults or those with multiple health conditions might face increased risks due to altered pharmacodynamics and pharmacokinetics [<xref rid="REF23" ref-type="bibr">23</xref>]. Effective monitoring of patients receiving adjuvants requires a pre-administration assessment to evaluate the patient's history of allergies and previous reactions to adjuvants or local anesthetics. Post-administration monitoring is crucial, especially within the first hour, as this is when most acute side effects are likely to manifest. Detailed documentation of any adverse effects experienced by patients is essential for future reference and to inform ongoing safety evaluations [<xref rid="REF7" ref-type="bibr">7</xref>]. Optimizing the dose is crucial to minimize risks associated with adjuvants. Using the lowest effective dose to achieve the desired effect can help reduce the likelihood of adverse reactions. Patient education is also important; informing patients about potential side effects and reporting any unusual symptoms post-administration is essential. For patients with known sensitivities or those at high risk for adverse effects, considering alternative adjuvants or techniques that pose less risk is recommended [<xref rid="REF24" ref-type="bibr">24</xref>]. The safety and side effects of common adjuvants used in anesthesia blocks are summarized in Table <xref rid="TAB1" ref-type="table">1</xref>.</p><table-wrap position="float" id="TAB1" orientation="portrait"><label>Table 1</label><caption><title>Safety and side effects of common adjuvants used in anesthesia blocks</title></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Adjuvant</td><td rowspan="1" colspan="1">Common Side Effects</td><td rowspan="1" colspan="1">Severe Adverse Reactions</td><td rowspan="1" colspan="1">Reported Incidence</td><td rowspan="1" colspan="1">Notes on Safety</td></tr><tr><td rowspan="1" colspan="1">Epinephrine [<xref rid="REF25" ref-type="bibr">25</xref>]</td><td rowspan="1" colspan="1">Increased heart rate, tremors</td><td rowspan="1" colspan="1">Myocardial ischemia, arrhythmias</td><td rowspan="1" colspan="1">Low</td><td rowspan="1" colspan="1">Generally safe in low doses, monitor cardiac patients carefully.</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Dexmedetomidine [<xref rid="REF26" ref-type="bibr">26</xref>]</td><td rowspan="1" colspan="1">Bradycardia, hypotension</td><td rowspan="1" colspan="1">Severe hypotension, rebound hypertension</td><td rowspan="1" colspan="1">Moderate</td><td rowspan="1" colspan="1">Use with caution in patients with cardiovascular conditions.</td></tr><tr><td rowspan="1" colspan="1">Clonidine [<xref rid="REF27" ref-type="bibr">27</xref>]</td><td rowspan="1" colspan="1">Hypotension, sedation</td><td rowspan="1" colspan="1">Severe hypotension, bradycardia</td><td rowspan="1" colspan="1">Moderate</td><td rowspan="1" colspan="1">It can prolong the block duration significantly but requires careful monitoring.</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Ketamine [<xref rid="REF28" ref-type="bibr">28</xref>]</td><td rowspan="1" colspan="1">Dizziness, nausea</td><td rowspan="1" colspan="1">Hallucinations, increased intracranial pressure</td><td rowspan="1" colspan="1">Low</td><td rowspan="1" colspan="1">Effective for pain relief but can cause psychomimetic effects in some patients.</td></tr><tr><td rowspan="1" colspan="1">Magnesium Sulfate [<xref rid="REF29" ref-type="bibr">29</xref>]</td><td rowspan="1" colspan="1">Flushing, hypotension</td><td rowspan="1" colspan="1">Respiratory depression, muscle weakness</td><td rowspan="1" colspan="1">Low</td><td rowspan="1" colspan="1">Considered safe in controlled doses, careful monitoring of respiratory function is required.</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Buprenorphine [<xref rid="REF30" ref-type="bibr">30</xref>]</td><td rowspan="1" colspan="1">Nausea, vomiting, dizziness</td><td rowspan="1" colspan="1">Respiratory depression, severe bradycardia</td><td rowspan="1" colspan="1">Low</td><td rowspan="1" colspan="1">Long-lasting effects, but respiratory depression is a concern in sensitive patients.</td></tr><tr><td rowspan="1" colspan="1">Dexamethasone [<xref rid="REF31" ref-type="bibr">31</xref>]</td><td rowspan="1" colspan="1">Hyperglycemia, mood changes</td><td rowspan="1" colspan="1">Immunosuppression, peptic ulcers</td><td rowspan="1" colspan="1">Moderate</td><td rowspan="1" colspan="1">Well-tolerated but should be avoided in diabetic and immunocompromised patients.</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Midazolam [<xref rid="REF32" ref-type="bibr">32</xref>]</td><td rowspan="1" colspan="1">Sedation, respiratory depression</td><td rowspan="1" colspan="1">Apnea, paradoxical reactions</td><td rowspan="1" colspan="1">Moderate</td><td rowspan="1" colspan="1">Short-acting but can cause significant respiratory issues in higher doses.</td></tr></tbody></table></table-wrap><p>Practical considerations in clinical practice</p><p>When integrating adjuvants into anesthesia practice, careful consideration of dosage, administration techniques, and patient-specific factors is essential to achieve optimal outcomes and minimize risks associated with anesthesia blocks [<xref rid="REF7" ref-type="bibr">7</xref>]. The recommended dosages of local anesthetics depend on the specific agent used and the type of block performed. For example, bupivacaine is commonly administered as a 0.25% to 0.5% solution, with a maximum dosage of 175 mg for PNBs. Ropivacaine, another frequently used local anesthetic, is given in concentrations ranging from 0.2% to 0.75%, with a maximum of 200 mg for PNBs [<xref rid="REF33" ref-type="bibr">33</xref>]. Adjuvants also have specific recommended dosages: dexamethasone is typically used at doses of 4-10 mg perineurally, clonidine at 1-2 mcg/kg (not exceeding 150 mcg per block), and dexmedetomidine and magnesium at dosages of 0.5-1 mcg/kg and 30-50 mg/kg, respectively [<xref rid="REF7" ref-type="bibr">7</xref>]. Administration techniques are critical for the effectiveness of adjuvants. Perineural administration, which involves direct injection around the nerve, can enhance local effects and minimize systemic absorption. When combining adjuvants with local anesthetics, ensuring compatibility to prevent precipitation or degradation of the solutions is essential [<xref rid="REF7" ref-type="bibr">7</xref>]. Maintaining the total injection volume within safe limits is important to minimize tissue trauma and ensure effective spread. Continuous monitoring of patients for signs of adverse reactions, particularly with opioids or alpha-2 agonists, is crucial for patient safety. Proper documentation of dosages and combinations used, along with the rationale for their selection, ensures continuity of care and aids in future treatment decisions [<xref rid="REF34" ref-type="bibr">34</xref>]. Patient-specific factors significantly influence the use of adjuvants in anesthesia. Age is key; pediatric patients often require dosage adjustments due to metabolism and body composition differences, necessitating smaller volumes and lower concentrations. Conversely, elderly patients may show increased sensitivity to anesthetics and adjuvants, requiring careful dosage adjustments and close monitoring for prolonged effects [<xref rid="REF35" ref-type="bibr">35</xref>]. Comorbidities also play a significant role; patients with cardiovascular conditions may be more susceptible to the effects of certain adjuvants, such as clonidine and dexmedetomidine, which can cause bradycardia or hypotension. Renal or hepatic impairment can affect drug clearance, further necessitating dosage adjustments and vigilant monitoring [<xref rid="REF36" ref-type="bibr">36</xref>]. Obesity is another important consideration, as dosage adjustments may be required based on lean body mass, especially for lipophilic agents like bupivacaine. A thorough preoperative assessment is essential to identify these patient-specific factors that may influence the choice and dosage of adjuvants [<xref rid="REF37" ref-type="bibr">37</xref>]. Tailoring the use of adjuvants based on a patient&#8217;s pain history, previous responses to anesthesia, and specific surgical procedures is crucial for optimizing outcomes. A multimodal analgesia approach can enhance pain management, including non-pharmacological methods such as physical therapy and cognitive-behavioral strategies [<xref rid="REF38" ref-type="bibr">38</xref>]. Practical considerations for the use of adjuvants in clinical anesthesia practice are summarized in Table <xref rid="TAB2" ref-type="table">2</xref>.</p><table-wrap position="float" id="TAB2" orientation="portrait"><label>Table 2</label><caption><title>Practical considerations for the use of adjuvants in clinical anesthesia practice</title></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Adjuvant</td><td rowspan="1" colspan="1">Optimal Dosage Range</td><td rowspan="1" colspan="1">Onset of Action</td><td rowspan="1" colspan="1">Duration of Action</td><td rowspan="1" colspan="1">Clinical Application</td><td rowspan="1" colspan="1">Special Considerations</td></tr><tr><td rowspan="1" colspan="1">Epinephrine [<xref rid="REF2" ref-type="bibr">2</xref>]</td><td rowspan="1" colspan="1">5-20 mcg/mL</td><td rowspan="1" colspan="1">Rapid (within minutes)</td><td rowspan="1" colspan="1">Short (10-20 minutes)</td><td rowspan="1" colspan="1">Prolongs local anesthetic effect reduces bleeding</td><td rowspan="1" colspan="1">Use cautiously in cardiac patients; avoid in-end arteries.</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Dexmedetomidine [<xref rid="REF39" ref-type="bibr">39</xref>]</td><td rowspan="1" colspan="1">0.5-1 mcg/kg</td><td rowspan="1" colspan="1">10-15 minutes</td><td rowspan="1" colspan="1">Long (up to 6 hours)</td><td rowspan="1" colspan="1">Enhances analgesia, reduces opioid requirements</td><td rowspan="1" colspan="1">It may cause hypotension and bradycardia, especially in the elderly.</td></tr><tr><td rowspan="1" colspan="1">Clonidine [<xref rid="REF40" ref-type="bibr">40</xref>]</td><td rowspan="1" colspan="1">0.5-2 mcg/kg</td><td rowspan="1" colspan="1">15-30 minutes</td><td rowspan="1" colspan="1">Long (6-8 hours)</td><td rowspan="1" colspan="1">Prolongs anesthesia duration, provides postoperative pain relief</td><td rowspan="1" colspan="1">Monitor for hypotension and bradycardia, especially in prolonged use.</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Ketamine [<xref rid="REF41" ref-type="bibr">41</xref>]</td><td rowspan="1" colspan="1">0.1-0.5 mg/kg</td><td rowspan="1" colspan="1">Rapid (within minutes)</td><td rowspan="1" colspan="1">Short (30-60 minutes)</td><td rowspan="1" colspan="1">Effective for short procedures, reduces opioid consumption</td><td rowspan="1" colspan="1">It may cause psychomimetic effects; avoid it in patients with elevated ICP.</td></tr><tr><td rowspan="1" colspan="1">Magnesium Sulfate [<xref rid="REF42" ref-type="bibr">42</xref>]</td><td rowspan="1" colspan="1">30-50 mg/kg</td><td rowspan="1" colspan="1">20-30 minutes</td><td rowspan="1" colspan="1">Moderate (up to 2 hours)</td><td rowspan="1" colspan="1">Potentiates local anesthetics, reduces pain</td><td rowspan="1" colspan="1">Monitor serum magnesium levels to prevent toxicity.</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Buprenorphine [<xref rid="REF30" ref-type="bibr">30</xref>]</td><td rowspan="1" colspan="1">0.1-0.3 mg</td><td rowspan="1" colspan="1">15-30 minutes</td><td rowspan="1" colspan="1">Very long (up to 12 hours)</td><td rowspan="1" colspan="1">Long-lasting postoperative analgesia</td><td rowspan="1" colspan="1">Risk of respiratory depression, avoid in opioid-tolerant patients.</td></tr><tr><td rowspan="1" colspan="1">Dexamethasone [<xref rid="REF13" ref-type="bibr">13</xref>]</td><td rowspan="1" colspan="1">4-10 mg</td><td rowspan="1" colspan="1">10-20 minutes</td><td rowspan="1" colspan="1">Long (12-24 hours)</td><td rowspan="1" colspan="1">Reduces inflammation and prolongs block duration</td><td rowspan="1" colspan="1">Avoid in diabetic patients due to the risk of hyperglycemia.</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Midazolam [<xref rid="REF32" ref-type="bibr">32</xref>]</td><td rowspan="1" colspan="1">1-2 mg</td><td rowspan="1" colspan="1">5-10 minutes</td><td rowspan="1" colspan="1">Short (2-4 hours)</td><td rowspan="1" colspan="1">Adjunct for sedation and anxiety relief</td><td rowspan="1" colspan="1">Risk of respiratory depression in high doses or prolonged use.</td></tr></tbody></table></table-wrap><p>Future directions and research</p><p>The field of adjuvant research is rapidly evolving, with several new adjuvants and innovative delivery systems being explored to enhance the efficacy and duration of anesthesia blocks. Notable trends include the development of next-generation adjuvants that target pathways beyond traditional pattern recognition receptors (PRRs). These new adjuvants leverage mechanisms such as metabolic alterations, epigenetic modifications, and the release of damage-associated molecular patterns (DAMPs) to elicit a more robust immune response [<xref rid="REF43" ref-type="bibr">43</xref>]. Advances in materials science are contributing to the creation of adjuvants that incorporate molecular adjuvants, polymers, lipids, and inorganic nanoparticles. These developments aim to improve antigen delivery and enhance immune responses, particularly in challenging fields such as cancer immunotherapy. Additionally, the use of multiple adjuvants in a single formulation is gaining momentum due to its potential to create synergistic effects that boost both humoral and cellular immunity, which is particularly beneficial for vaccines targeting complex pathogens. The focus is also shifting toward&#160;synthetic adjuvants that can be produced at scale with consistent quality, offering advantages over traditional natural components in terms of reduced variability and improved safety profiles [<xref rid="REF44" ref-type="bibr">44</xref>]. Despite these advancements, several gaps remain in the understanding and applying adjuvants in anesthesia. There is a pressing need for a more systematic exploration of how different adjuvants enhance local anesthetics. A deeper understanding of these mechanisms could lead to the rational design of adjuvant combinations tailored to specific clinical scenarios. Many promising adjuvants are still preclinical, and their safety and efficacy in human subjects require thorough investigation. Future research should prioritize clinical trials to validate the effectiveness of new adjuvants and delivery systems in real-world settings [<xref rid="REF7" ref-type="bibr">7</xref>]. Given the variability in patient responses to anesthesia, personalized medicine approaches could be advantageous. Investigating how individual genetic and immunological profiles affect adjuvant responses could lead to more effective and tailored anesthetic strategies. Moreover, the development of adjuvants should consider sustainability in sourcing materials and the feasibility of large-scale production, as addressing these factors will be crucial for ensuring that new adjuvants are accessible and practical for widespread clinical use [<xref rid="REF45" ref-type="bibr">45</xref>]. Future directions and research in the use of adjuvants for anesthesia blocks are summarized in Table <xref rid="TAB3" ref-type="table">3</xref>.</p><table-wrap position="float" id="TAB3" orientation="portrait"><label>Table 3</label><caption><title>Future directions and research in the use of adjuvants for anesthesia blocks</title></caption><table frame="hsides" rules="groups"><tbody><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Area of Research</td><td rowspan="1" colspan="1">Key Focus</td><td rowspan="1" colspan="1">Potential Benefits</td><td rowspan="1" colspan="1">Challenges/Limitations</td><td rowspan="1" colspan="1">Current Status</td></tr><tr><td rowspan="1" colspan="1">Novel Adjuvants [<xref rid="REF46" ref-type="bibr">46</xref>]</td><td rowspan="1" colspan="1">Development of new adjuvants with minimal side effects</td><td rowspan="1" colspan="1">Enhanced safety and efficacy, longer block duration</td><td rowspan="1" colspan="1">Limited clinical trials, regulatory hurdles</td><td rowspan="1" colspan="1">Early-phase trials and preclinical studies</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Personalized Medicine in Anesthesia [<xref rid="REF45" ref-type="bibr">45</xref>]</td><td rowspan="1" colspan="1">Tailoring adjuvant use based on patient genetics</td><td rowspan="1" colspan="1">Optimized dosing, reduced side effects, individualized care</td><td rowspan="1" colspan="1">Need for genetic testing infrastructure, cost concerns</td><td rowspan="1" colspan="1">Ongoing research in pharmacogenomics</td></tr><tr><td rowspan="1" colspan="1">Long-Term Safety Studies [<xref rid="REF47" ref-type="bibr">47</xref>]</td><td rowspan="1" colspan="1">Assessing long-term effects of adjuvant use</td><td rowspan="1" colspan="1">Better understanding of chronic side effects</td><td rowspan="1" colspan="1">Requires long-term follow-up and large patient cohorts</td><td rowspan="1" colspan="1">Few long-term studies are available</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Combination Therapies [<xref rid="REF48" ref-type="bibr">48</xref>]</td><td rowspan="1" colspan="1">Exploring the synergistic effects of multiple adjuvants</td><td rowspan="1" colspan="1">Increased efficacy, reduced doses of individual adjuvants</td><td rowspan="1" colspan="1">Complex interactions, risk of enhanced side effects</td><td rowspan="1" colspan="1">Preliminary studies showing promise</td></tr><tr><td rowspan="1" colspan="1">Adjuvants for Regional Anesthesia in Special Populations [<xref rid="REF49" ref-type="bibr">49</xref>]</td><td rowspan="1" colspan="1">Focusing on geriatric, pediatric, and high-risk patients</td><td rowspan="1" colspan="1">Improved outcomes in vulnerable populations</td><td rowspan="1" colspan="1">Higher risk of adverse events need for cautious dosing</td><td rowspan="1" colspan="1">Research in specialized patient groups is growing</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">Mechanisms of Action [<xref rid="REF50" ref-type="bibr">50</xref>]</td><td rowspan="1" colspan="1">Understanding how adjuvants modulate nerve conduction</td><td rowspan="1" colspan="1">Insights into improving effectiveness and reducing side effects</td><td rowspan="1" colspan="1">Mechanistic studies can be complex and require advanced technology</td><td rowspan="1" colspan="1">Research progressing but incomplete</td></tr><tr><td rowspan="1" colspan="1">Non-Pharmacological Enhancements [<xref rid="REF51" ref-type="bibr">51</xref>]</td><td rowspan="1" colspan="1">Integration of adjuvants with non-pharmacological techniques (e.g., ultrasound)</td><td rowspan="1" colspan="1">Enhanced precision, reduced drug dosage</td><td rowspan="1" colspan="1">Requires specialized training and equipment</td><td rowspan="1" colspan="1">Growing interest, especially in advanced clinical settings</td></tr><tr style="background-color:#ccc"><td rowspan="1" colspan="1">AI and Machine Learning in Adjuvant Selection [<xref rid="REF52" ref-type="bibr">52</xref>]</td><td rowspan="1" colspan="1">Using AI to predict optimal adjuvants and dosing</td><td rowspan="1" colspan="1">Personalized regimens, reduced adverse reactions</td><td rowspan="1" colspan="1">Requires large data sets, algorithm transparency</td><td rowspan="1" colspan="1">Emerging field with ongoing pilot studies</td></tr></tbody></table></table-wrap></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In conclusion, integrating adjuvants into anesthesia practice represents a significant advancement in managing pain during and after surgical procedures. By enhancing the efficacy and extending the duration of anesthesia blocks, adjuvants improve the quality of pain relief and contribute to a more tailored and patient-centered approach to anesthesia. Their ability to reduce the need for higher doses of local anesthetics and mitigate systemic side effects underscores their value in optimizing anesthesia outcomes. As research continues to evolve and new adjuvants are explored, the potential for further enhancing pain management and improving patient experiences remains promising. Ultimately, the judicious use of adjuvants will continue to play a crucial role in refining anesthesia techniques, ensuring safer and more effective pain control for diverse clinical scenarios.</p></sec></body><back><ack><p>We acknowledge the valuable assistance provided by ChatGPT (OpenAI, San Francisco, California) in offering insightful suggestions for ensuring clarity and precision in our writing with Grammarly and Paperpal to enhance the quality and accuracy of our work.</p></ack><fn-group content-type="conflict"><title>Disclosures</title><fn fn-type="COI-statement"><p><bold>Conflicts of interest:</bold> In compliance with the ICMJE uniform disclosure form, all authors declare the following:</p><p><bold>Payment/services info:</bold> All authors have declared that no financial support was received from any organization for the submitted work.</p><p><bold>Financial relationships:</bold> All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.</p><p><bold>Other relationships:</bold> All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</p></fn></fn-group><fn-group content-type="other"><title>Author Contributions</title><fn fn-type="other"><p><bold>Concept and design:</bold>&#160; Akansha Singhal, Karuna Taksande</p><p><bold>Acquisition, analysis, or interpretation of data:</bold>&#160; Akansha Singhal, Karuna Taksande</p><p><bold>Drafting of the manuscript:</bold>&#160; Akansha Singhal, Karuna Taksande</p><p><bold>Critical review of the manuscript for important intellectual content:</bold>&#160; Akansha Singhal, Karuna Taksande</p><p><bold>Supervision:</bold>&#160; Akansha Singhal, Karuna Taksande</p></fn></fn-group><ref-list><title>References</title><ref id="REF1"><label>1</label><element-citation publication-type="webpage"><article-title>National Institute of General Medical Sciences. National Institute of General Medical Sciences (NIGMS)</article-title><date-in-citation content-type="access-date"><month>9</month><year>2024</year></date-in-citation><year>2023</year><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://nigms.nih.gov/">https://nigms.nih.gov/</uri></element-citation></ref><ref id="REF2"><label>2</label><element-citation publication-type="journal"><article-title>Local anesthetics: review of pharmacological considerations</article-title><source>Anesth Prog</source><person-group><name name-style="western"><surname>Becker</surname><given-names>DE</given-names></name><name name-style="western"><surname>Reed</surname><given-names>KL</given-names></name></person-group><fpage>90</fpage><lpage>3</lpage><volume>59</volume><year>2012</year><pub-id pub-id-type="pmid">22822998</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2344/0003-3006-59.2.90</pub-id><pub-id pub-id-type="pmcid">PMC3403589</pub-id></element-citation></ref><ref id="REF3"><label>3</label><element-citation publication-type="book"><article-title>Regional anesthetic blocks</article-title><person-group><name name-style="western"><surname>Folino</surname><given-names>TB</given-names></name><name name-style="western"><surname>Mahboobi</surname><given-names>SK</given-names></name></person-group><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2024</year><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK563238/">https://www.ncbi.nlm.nih.gov/books/NBK563238/</uri><pub-id pub-id-type="pmid">33085385</pub-id></element-citation></ref><ref id="REF4"><label>4</label><element-citation publication-type="journal"><article-title>Navigating pain relief: a comprehensive review of transversus abdominis plane block</article-title><source>Cureus</source><person-group><name name-style="western"><surname>Ghosh</surname><given-names>A</given-names></name><name name-style="western"><surname>Ninave</surname><given-names>S</given-names></name></person-group><fpage>0</fpage><volume>15</volume><year>2023</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.51119</pub-id><pub-id pub-id-type="pmcid">PMC10808892</pub-id><pub-id pub-id-type="pmid">38274920</pub-id></element-citation></ref><ref id="REF5"><label>5</label><element-citation publication-type="book"><article-title>Postoperative pain control</article-title><person-group><name name-style="western"><surname>Horn</surname><given-names>R</given-names></name><name name-style="western"><surname>Hendrix</surname><given-names>JM</given-names></name><name name-style="western"><surname>Kramer</surname><given-names>J</given-names></name></person-group><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2024</year><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK544298/">https://www.ncbi.nlm.nih.gov/books/NBK544298/</uri><pub-id pub-id-type="pmid">31335018</pub-id></element-citation></ref><ref id="REF6"><label>6</label><element-citation publication-type="journal"><article-title>Review of adjuvants to local anesthetics in peripheral nerve blocks: current and future trends</article-title><source>Saudi J Anaesth</source><person-group><name name-style="western"><surname>Krishna Prasad</surname><given-names>GV</given-names></name><name name-style="western"><surname>Khanna</surname><given-names>S</given-names></name><name name-style="western"><surname>Jaishree</surname><given-names>SV</given-names></name></person-group><fpage>77</fpage><lpage>84</lpage><volume>14</volume><year>2020</year><pub-id pub-id-type="pmid">31998024</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/sja.SJA_423_19</pub-id><pub-id pub-id-type="pmcid">PMC6970354</pub-id></element-citation></ref><ref id="REF7"><label>7</label><element-citation publication-type="journal"><article-title>Adjuvants to local anesthetics: current understanding and future trends</article-title><source>World J Clin Cases</source><person-group><name name-style="western"><surname>Swain</surname><given-names>A</given-names></name><name name-style="western"><surname>Nag</surname><given-names>DS</given-names></name><name name-style="western"><surname>Sahu</surname><given-names>S</given-names></name><name name-style="western"><surname>Samaddar</surname><given-names>DP</given-names></name></person-group><fpage>307</fpage><lpage>323</lpage><volume>5</volume><year>2017</year><pub-id pub-id-type="pmid">28868303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12998/wjcc.v5.i8.307</pub-id><pub-id pub-id-type="pmcid">PMC5561500</pub-id></element-citation></ref><ref id="REF8"><label>8</label><element-citation publication-type="book"><article-title>Opioid anesthesia</article-title><person-group><name name-style="western"><surname>Ferry</surname><given-names>N</given-names></name><name name-style="western"><surname>Hancock</surname><given-names>LE</given-names></name><name name-style="western"><surname>Dhanjal</surname><given-names>S</given-names></name></person-group><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2024</year><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK532956/">https://www.ncbi.nlm.nih.gov/books/NBK532956/</uri><pub-id pub-id-type="pmid">30422551</pub-id></element-citation></ref><ref id="REF9"><label>9</label><element-citation publication-type="journal"><article-title>Analgesic effect of the topical use of dexamethasone in ultrasound-guided axillary brachial plexus blockade: a prospective, randomized, double-blind, placebo-controlled study</article-title><source>Cureus</source><person-group><name name-style="western"><surname>Chazapi</surname><given-names>A</given-names></name><name name-style="western"><surname>Lepetsos</surname><given-names>P</given-names></name><name name-style="western"><surname>Gambopoulou</surname><given-names>Z</given-names></name><name name-style="western"><surname>Siafaka</surname><given-names>I</given-names></name><name name-style="western"><surname>Argyra</surname><given-names>E</given-names></name><name name-style="western"><surname>Vadalouka</surname><given-names>A</given-names></name></person-group><fpage>0</fpage><volume>13</volume><year>2021</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.12971</pub-id><pub-id pub-id-type="pmcid">PMC7913892</pub-id><pub-id pub-id-type="pmid">33654632</pub-id></element-citation></ref><ref id="REF10"><label>10</label><element-citation publication-type="journal"><article-title>Comparison of dexmedetomidine and clonidine (&#945;2 agonist drugs) as an adjuvant to local anaesthesia in supraclavicular brachial plexus block: a randomised double-blind prospective study</article-title><source>Indian J Anaesth</source><person-group><name name-style="western"><surname>Swami</surname><given-names>SS</given-names></name><name name-style="western"><surname>Keniya</surname><given-names>VM</given-names></name><name name-style="western"><surname>Ladi</surname><given-names>SD</given-names></name><name name-style="western"><surname>Rao</surname><given-names>R</given-names></name></person-group><fpage>243</fpage><lpage>249</lpage><volume>56</volume><year>2012</year><pub-id pub-id-type="pmid">22923822</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/0019-5049.98767</pub-id><pub-id pub-id-type="pmcid">PMC3425283</pub-id></element-citation></ref><ref id="REF11"><label>11</label><element-citation publication-type="book"><article-title>Nonsteroidal anti-inflammatory drugs (NSAIDs)</article-title><person-group><name name-style="western"><surname>Ghlichloo</surname><given-names>I</given-names></name><name name-style="western"><surname>Gerriets</surname><given-names>V</given-names></name></person-group><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2024</year><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK547742/">https://www.ncbi.nlm.nih.gov/books/NBK547742/</uri><pub-id pub-id-type="pmid">31613522</pub-id></element-citation></ref><ref id="REF12"><label>12</label><element-citation publication-type="journal"><article-title>Adjuvant drugs for peripheral nerve blocks: the role of NMDA antagonists, neostigmine, epinephrine, and sodium bicarbonate</article-title><source>Anesth Pain Med</source><person-group><name name-style="western"><surname>Edinoff</surname><given-names>AN</given-names></name><name name-style="western"><surname>Fitz-Gerald</surname><given-names>JS</given-names></name><name name-style="western"><surname>Holland</surname><given-names>KA</given-names></name><etal/></person-group><fpage>0</fpage><volume>11</volume><year>2021</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.5812/aapm.117146</pub-id><pub-id pub-id-type="pmcid">PMC8438710</pub-id><pub-id pub-id-type="pmid">34540646</pub-id></element-citation></ref><ref id="REF13"><label>13</label><element-citation publication-type="journal"><article-title>Dexamethasone as an adjuvant to peripheral nerve block</article-title><source>Cochrane Database Syst Rev</source><person-group><name name-style="western"><surname>Pehora</surname><given-names>C</given-names></name><name name-style="western"><surname>Pearson</surname><given-names>AM</given-names></name><name name-style="western"><surname>Kaushal</surname><given-names>A</given-names></name><name name-style="western"><surname>Crawford</surname><given-names>MW</given-names></name><name name-style="western"><surname>Johnston</surname><given-names>B</given-names></name></person-group><fpage>0</fpage><volume>11</volume><year>2017</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD011770.pub2</pub-id><pub-id pub-id-type="pmcid">PMC6486015</pub-id><pub-id pub-id-type="pmid">29121400</pub-id></element-citation></ref><ref id="REF14"><label>14</label><element-citation publication-type="journal"><article-title>Dexamethasone as adjuvant to bupivacaine prolongs the duration of thermal antinociception and prevents bupivacaine-induced rebound hyperalgesia via regional mechanism in a mouse sciatic nerve block model</article-title><source>PLoS One</source><person-group><name name-style="western"><surname>An</surname><given-names>K</given-names></name><name name-style="western"><surname>Elkassabany</surname><given-names>NM</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name></person-group><fpage>0</fpage><volume>10</volume><year>2015</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0123459</pub-id><pub-id pub-id-type="pmcid">PMC4391940</pub-id><pub-id pub-id-type="pmid">25856078</pub-id></element-citation></ref><ref id="REF15"><label>15</label><element-citation publication-type="journal"><article-title>Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta-analysis of randomized trials</article-title><source>Br J Anaesth</source><person-group><name name-style="western"><surname>Choi</surname><given-names>S</given-names></name><name name-style="western"><surname>Rodseth</surname><given-names>R</given-names></name><name name-style="western"><surname>McCartney</surname><given-names>CJ</given-names></name></person-group><fpage>427</fpage><lpage>439</lpage><volume>112</volume><year>2014</year><pub-id pub-id-type="pmid">24413428</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bja/aet417</pub-id></element-citation></ref><ref id="REF16"><label>16</label><element-citation publication-type="journal"><article-title>Alpha-2 adrenergic receptor agonists: a review of current clinical applications</article-title><source>Anesth Prog</source><person-group><name name-style="western"><surname>Giovannitti JA</surname><given-names>Jr</given-names></name><name name-style="western"><surname>Thoms</surname><given-names>SM</given-names></name><name name-style="western"><surname>Crawford</surname><given-names>JJ</given-names></name></person-group><fpage>31</fpage><lpage>39</lpage><volume>62</volume><year>2015</year><pub-id pub-id-type="pmid">25849473</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2344/0003-3006-62.1.31</pub-id><pub-id pub-id-type="pmcid">PMC4389556</pub-id></element-citation></ref><ref id="REF17"><label>17</label><element-citation publication-type="journal"><article-title>Clonidine as an adjuvant to ropivacaine-induced supraclavicular brachial plexus block for upper limb surgeries</article-title><source>J Anaesthesiol Clin Pharmacol</source><person-group><name name-style="western"><surname>Patil</surname><given-names>KN</given-names></name><name name-style="western"><surname>Singh</surname><given-names>ND</given-names></name></person-group><fpage>365</fpage><lpage>369</lpage><volume>31</volume><year>2015</year><pub-id pub-id-type="pmid">26330717</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/0970-9185.161674</pub-id><pub-id pub-id-type="pmcid">PMC4541185</pub-id></element-citation></ref><ref id="REF18"><label>18</label><element-citation publication-type="journal"><article-title>Spinal &#945;(2)-adrenoceptors and neuropathic pain modulation; therapeutic target</article-title><source>Br J Pharmacol</source><person-group><name name-style="western"><surname>Bahari</surname><given-names>Z</given-names></name><name name-style="western"><surname>Meftahi</surname><given-names>GH</given-names></name></person-group><fpage>2366</fpage><lpage>2381</lpage><volume>176</volume><year>2019</year><pub-id pub-id-type="pmid">30657594</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/bph.14580</pub-id><pub-id pub-id-type="pmcid">PMC6592871</pub-id></element-citation></ref><ref id="REF19"><label>19</label><element-citation publication-type="book"><article-title>The role of magnesium in pain</article-title><person-group><name name-style="western"><surname>Na</surname><given-names>HS</given-names></name><name name-style="western"><surname>Ryu</surname><given-names>JH</given-names></name><name name-style="western"><surname>Do</surname><given-names>SH</given-names></name></person-group><publisher-loc>Adelaide (AU)</publisher-loc><publisher-name>University of Adelaide Press</publisher-name><year>2011</year><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK507245/">https://www.ncbi.nlm.nih.gov/books/NBK507245/</uri><pub-id pub-id-type="pmid">29920000</pub-id></element-citation></ref><ref id="REF20"><label>20</label><element-citation publication-type="journal"><article-title>Adjuvants in peripheral nerve blocks - the current state of knowledge</article-title><source>Anaesthesiol Intensive Ther</source><person-group><name name-style="western"><surname>Gola</surname><given-names>W</given-names></name><name name-style="western"><surname>Zaj&#261;c</surname><given-names>M</given-names></name><name name-style="western"><surname>Cugowski</surname><given-names>A</given-names></name></person-group><fpage>323</fpage><lpage>329</lpage><volume>52</volume><year>2020</year><pub-id pub-id-type="pmid">33165883</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5114/ait.2020.98213</pub-id><pub-id pub-id-type="pmcid">PMC10183787</pub-id></element-citation></ref><ref id="REF21"><label>21</label><element-citation publication-type="journal"><article-title>A comparative study of intrathecal clonidine and dexmedetomidine on characteristics of bupivacaine spinal block for lower limb surgeries</article-title><source>Anesth Essays Res</source><person-group><name name-style="western"><surname>Sarma</surname><given-names>J</given-names></name><name name-style="western"><surname>Narayana</surname><given-names>PS</given-names></name><name name-style="western"><surname>Ganapathi</surname><given-names>P</given-names></name><name name-style="western"><surname>Shivakumar</surname><given-names>MC</given-names></name></person-group><fpage>195</fpage><lpage>207</lpage><volume>9</volume><year>2015</year><pub-id pub-id-type="pmid">26417127</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/0259-1162.153763</pub-id><pub-id pub-id-type="pmcid">PMC4563966</pub-id></element-citation></ref><ref id="REF22"><label>22</label><element-citation publication-type="journal"><article-title>Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double-blinded randomized clinical study</article-title><source>J Anaesthesiol Clin Pharmacol</source><person-group><name name-style="western"><surname>Alarasan</surname><given-names>AK</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>J</given-names></name><name name-style="western"><surname>Choudhary</surname><given-names>B</given-names></name><name name-style="western"><surname>Melhotra</surname><given-names>A</given-names></name><name name-style="western"><surname>Uike</surname><given-names>S</given-names></name><name name-style="western"><surname>Mukherji</surname><given-names>A</given-names></name></person-group><fpage>234</fpage><lpage>239</lpage><volume>32</volume><year>2016</year><pub-id pub-id-type="pmid">27275056</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/0970-9185.182108</pub-id><pub-id pub-id-type="pmcid">PMC4874081</pub-id></element-citation></ref><ref id="REF23"><label>23</label><element-citation publication-type="journal"><article-title>Safety assessment of adjuvanted vaccines: methodological considerations</article-title><source>Hum Vaccin Immunother</source><person-group><name name-style="western"><surname>Tavares Da Silva</surname><given-names>F</given-names></name><name name-style="western"><surname>Di Pasquale</surname><given-names>A</given-names></name><name name-style="western"><surname>Yarzabal</surname><given-names>JP</given-names></name><name name-style="western"><surname>Gar&#231;on</surname><given-names>N</given-names></name></person-group><fpage>1814</fpage><lpage>1824</lpage><volume>11</volume><year>2015</year><pub-id pub-id-type="pmid">26029975</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/21645515.2015.1043501</pub-id><pub-id pub-id-type="pmcid">PMC4514270</pub-id></element-citation></ref><ref id="REF24"><label>24</label><element-citation publication-type="journal"><article-title>Toward precision adjuvants: optimizing science and safety</article-title><source>Curr Opin Pediatr</source><person-group><name name-style="western"><surname>Nanishi</surname><given-names>E</given-names></name><name name-style="western"><surname>Dowling</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Levy</surname><given-names>O</given-names></name></person-group><fpage>125</fpage><lpage>138</lpage><volume>32</volume><year>2020</year><pub-id pub-id-type="pmid">31904601</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MOP.0000000000000868</pub-id><pub-id pub-id-type="pmcid">PMC6970548</pub-id></element-citation></ref><ref id="REF25"><label>25</label><element-citation publication-type="book"><article-title>Epinephrine</article-title><person-group><name name-style="western"><surname>Dalal</surname><given-names>R</given-names></name><name name-style="western"><surname>Grujic</surname><given-names>D</given-names></name></person-group><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2024</year><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK482160/">https://www.ncbi.nlm.nih.gov/books/NBK482160/</uri><pub-id pub-id-type="pmid">29489283</pub-id></element-citation></ref><ref id="REF26"><label>26</label><element-citation publication-type="book"><article-title>Dexmedetomidine</article-title><person-group><name name-style="western"><surname>Reel</surname><given-names>B</given-names></name><name name-style="western"><surname>Maani</surname><given-names>CV</given-names></name></person-group><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2024</year><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK513303/">https://www.ncbi.nlm.nih.gov/books/NBK513303/</uri><pub-id pub-id-type="pmid">30020675</pub-id></element-citation></ref><ref id="REF27"><label>27</label><element-citation publication-type="book"><article-title>Clonidine</article-title><person-group><name name-style="western"><surname>Yasaei</surname><given-names>R</given-names></name><name name-style="western"><surname>Saadabadi</surname><given-names>A</given-names></name></person-group><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2024</year><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK459124/">https://www.ncbi.nlm.nih.gov/books/NBK459124/</uri><pub-id pub-id-type="pmid">29083638</pub-id></element-citation></ref><ref id="REF28"><label>28</label><element-citation publication-type="book"><article-title>Ketamine toxicity</article-title><person-group><name name-style="western"><surname>Orhurhu</surname><given-names>VJ</given-names></name><name name-style="western"><surname>Vashisht</surname><given-names>R</given-names></name><name name-style="western"><surname>Claus</surname><given-names>LE</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>SP</given-names></name></person-group><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2024</year><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK541087/">https://www.ncbi.nlm.nih.gov/books/NBK541087/</uri><pub-id pub-id-type="pmid">31082131</pub-id></element-citation></ref><ref id="REF29"><label>29</label><element-citation publication-type="book"><article-title>Magnesium sulfate</article-title><person-group><name name-style="western"><surname>Hicks</surname><given-names>MA</given-names></name><name name-style="western"><surname>Tyagi</surname><given-names>A</given-names></name></person-group><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2024</year><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK554553/">https://www.ncbi.nlm.nih.gov/books/NBK554553/</uri><pub-id pub-id-type="pmid">32119440</pub-id></element-citation></ref><ref id="REF30"><label>30</label><element-citation publication-type="book"><article-title>Buprenorphine</article-title><person-group><name name-style="western"><surname>Kumar</surname><given-names>R</given-names></name><name name-style="western"><surname>Viswanath</surname><given-names>O</given-names></name><name name-style="western"><surname>Saadabadi</surname><given-names>A</given-names></name></person-group><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2024</year><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK459126/">https://www.ncbi.nlm.nih.gov/books/NBK459126/</uri><pub-id pub-id-type="pmid">29083570</pub-id></element-citation></ref><ref id="REF31"><label>31</label><element-citation publication-type="journal"><article-title>Dexamethasone and postoperative hyperglycemia in diabetics undergoing elective hip or knee arthroplasty: a case control study in 238 patients</article-title><source>Patient Saf Surg</source><person-group><name name-style="western"><surname>O'Connell</surname><given-names>RS</given-names></name><name name-style="western"><surname>Clinger</surname><given-names>BN</given-names></name><name name-style="western"><surname>Donahue</surname><given-names>EE</given-names></name><name name-style="western"><surname>Celi</surname><given-names>FS</given-names></name><name name-style="western"><surname>Golladay</surname><given-names>GJ</given-names></name></person-group><fpage>30</fpage><volume>12</volume><year>2018</year><pub-id pub-id-type="pmid">30410577</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13037-018-0178-9</pub-id><pub-id pub-id-type="pmcid">PMC6217772</pub-id></element-citation></ref><ref id="REF32"><label>32</label><element-citation publication-type="book"><article-title>Midazolam</article-title><person-group><name name-style="western"><surname>Lingamchetty</surname><given-names>TN</given-names></name><name name-style="western"><surname>Hosseini</surname><given-names>SA</given-names></name><name name-style="western"><surname>Saadabadi</surname><given-names>A</given-names></name></person-group><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2024</year><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK537321/">https://www.ncbi.nlm.nih.gov/books/NBK537321/</uri><pub-id pub-id-type="pmid">30726006</pub-id></element-citation></ref><ref id="REF33"><label>33</label><element-citation publication-type="journal"><article-title>Comparative study of analgesia with bupivacaine 0.25% versus 0.5% for third molar removal under general anesthesia</article-title><source>J Dent Anesth Pain Med</source><person-group><name name-style="western"><surname>Dhanrajani</surname><given-names>P</given-names></name><name name-style="western"><surname>Chung</surname><given-names>P</given-names></name></person-group><fpage>117</fpage><lpage>122</lpage><volume>16</volume><year>2016</year><pub-id pub-id-type="pmid">28879304</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.17245/jdapm.2016.16.2.117</pub-id><pub-id pub-id-type="pmcid">PMC5564080</pub-id></element-citation></ref><ref id="REF34"><label>34</label><element-citation publication-type="book"><article-title>Alpha-adrenergic receptors</article-title><person-group><name name-style="western"><surname>Taylor</surname><given-names>BN</given-names></name><name name-style="western"><surname>Cassagnol</surname><given-names>M</given-names></name></person-group><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2024</year><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK539830/">https://www.ncbi.nlm.nih.gov/books/NBK539830/</uri><pub-id pub-id-type="pmid">30969652</pub-id></element-citation></ref><ref id="REF35"><label>35</label><element-citation publication-type="journal"><article-title>Pharmacology related to paediatric anaesthesia</article-title><source>Indian J Anaesth</source><person-group><name name-style="western"><surname>Maheshwari</surname><given-names>M</given-names></name><name name-style="western"><surname>Sanwatsarkar</surname><given-names>S</given-names></name><name name-style="western"><surname>Katakwar</surname><given-names>M</given-names></name></person-group><fpage>698</fpage><lpage>706</lpage><volume>63</volume><year>2019</year><pub-id pub-id-type="pmid">31571682</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/ija.IJA_487_19</pub-id><pub-id pub-id-type="pmcid">PMC6761782</pub-id></element-citation></ref><ref id="REF36"><label>36</label><element-citation publication-type="journal"><article-title>Dexmedetomidine: a novel sedative-analgesic agent</article-title><source>Proc (Bayl Univ Med Cent)</source><person-group><name name-style="western"><surname>Gertler</surname><given-names>R</given-names></name><name name-style="western"><surname>Brown</surname><given-names>HC</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>DH</given-names></name><name name-style="western"><surname>Silvius</surname><given-names>EN</given-names></name></person-group><fpage>13</fpage><lpage>21</lpage><volume>14</volume><year>2001</year><pub-id pub-id-type="pmid">16369581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08998280.2001.11927725</pub-id><pub-id pub-id-type="pmcid">PMC1291306</pub-id></element-citation></ref><ref id="REF37"><label>37</label><element-citation publication-type="journal"><article-title>General anesthetic care of obese patients undergoing surgery: a review of current anesthetic considerations and recent advances</article-title><source>Cureus</source><person-group><name name-style="western"><surname>Waheed</surname><given-names>Z</given-names></name><name name-style="western"><surname>Amatul-Hadi</surname><given-names>F</given-names></name><name name-style="western"><surname>Kooner</surname><given-names>A</given-names></name><etal/></person-group><fpage>0</fpage><volume>15</volume><year>2023</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.41565</pub-id><pub-id pub-id-type="pmcid">PMC10405976</pub-id><pub-id pub-id-type="pmid">37554600</pub-id></element-citation></ref><ref id="REF38"><label>38</label><element-citation publication-type="journal"><article-title>Pharmacological methods of pain management: narrative review of medication used</article-title><source>Int J Gen Med</source><person-group><name name-style="western"><surname>Alorfi</surname><given-names>NM</given-names></name></person-group><fpage>3247</fpage><lpage>3256</lpage><volume>16</volume><year>2023</year><pub-id pub-id-type="pmid">37546242</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJGM.S419239</pub-id><pub-id pub-id-type="pmcid">PMC10402723</pub-id></element-citation></ref><ref id="REF39"><label>39</label><element-citation publication-type="journal"><article-title>Dexmedetomidine in enhanced recovery after surgery (ERAS) protocols for postoperative pain</article-title><source>Curr Pain Headache Rep</source><person-group><name name-style="western"><surname>Kaye</surname><given-names>AD</given-names></name><name name-style="western"><surname>Chernobylsky</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Thakur</surname><given-names>P</given-names></name><etal/></person-group><fpage>21</fpage><volume>24</volume><year>2020</year><pub-id pub-id-type="pmid">32240402</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11916-020-00853-z</pub-id><pub-id pub-id-type="pmcid">PMC7223065</pub-id></element-citation></ref><ref id="REF40"><label>40</label><element-citation publication-type="journal"><article-title>Addition of clonidine or dexmedetomidine with bupivacaine to prolong caudal analgesia in children undergoing infraumbilical surgery</article-title><source>Cureus</source><person-group><name name-style="western"><surname>Gogoi</surname><given-names>S</given-names></name><name name-style="western"><surname>Saikia</surname><given-names>D</given-names></name><name name-style="western"><surname>Dey</surname><given-names>S</given-names></name></person-group><fpage>0</fpage><volume>14</volume><year>2022</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.23110</pub-id><pub-id pub-id-type="pmcid">PMC9001856</pub-id><pub-id pub-id-type="pmid">35464557</pub-id></element-citation></ref><ref id="REF41"><label>41</label><element-citation publication-type="journal"><article-title>Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists</article-title><source>Reg Anesth Pain Med</source><person-group><name name-style="western"><surname>Schwenk</surname><given-names>ES</given-names></name><name name-style="western"><surname>Viscusi</surname><given-names>ER</given-names></name><name name-style="western"><surname>Buvanendran</surname><given-names>A</given-names></name><etal/></person-group><fpage>456</fpage><lpage>466</lpage><volume>43</volume><year>2018</year><pub-id pub-id-type="pmid">29870457</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/AAP.0000000000000806</pub-id><pub-id pub-id-type="pmcid">PMC6023582</pub-id></element-citation></ref><ref id="REF42"><label>42</label><element-citation publication-type="journal"><article-title>Magnesium and pain</article-title><source>Nutrients</source><person-group><name name-style="western"><surname>Shin</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Na</surname><given-names>HS</given-names></name><name name-style="western"><surname>Do</surname><given-names>SH</given-names></name></person-group><fpage>2184</fpage><volume>12</volume><year>2020</year><pub-id pub-id-type="pmid">32718032</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/nu12082184</pub-id><pub-id pub-id-type="pmcid">PMC7468697</pub-id></element-citation></ref><ref id="REF43"><label>43</label><element-citation publication-type="journal"><article-title>Recent advances in the discovery and delivery of vaccine adjuvants</article-title><source>Nat Rev Drug Discov</source><person-group><name name-style="western"><surname>O'Hagan</surname><given-names>DT</given-names></name><name name-style="western"><surname>Valiante</surname><given-names>NM</given-names></name></person-group><fpage>727</fpage><lpage>735</lpage><volume>2</volume><year>2003</year><pub-id pub-id-type="pmid">12951579</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrd1176</pub-id><pub-id pub-id-type="pmcid">PMC7097252</pub-id></element-citation></ref><ref id="REF44"><label>44</label><element-citation publication-type="journal"><article-title>Applications of nanomaterials as vaccine adjuvants</article-title><source>Hum Vaccin Immunother</source><person-group><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name><name name-style="western"><surname>Nie</surname><given-names>G</given-names></name></person-group><fpage>2761</fpage><lpage>2774</lpage><volume>10</volume><year>2014</year><pub-id pub-id-type="pmid">25483497</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4161/hv.29589</pub-id><pub-id pub-id-type="pmcid">PMC4977448</pub-id></element-citation></ref><ref id="REF45"><label>45</label><element-citation publication-type="journal"><article-title>Personalized anesthesia and precision medicine: a comprehensive review of genetic factors, artificial intelligence, and patient-specific factors</article-title><source>Front Med (Lausanne)</source><person-group><name name-style="western"><surname>Zeng</surname><given-names>S</given-names></name><name name-style="western"><surname>Qing</surname><given-names>Q</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><etal/></person-group><fpage>1365524</fpage><volume>11</volume><year>2024</year><pub-id pub-id-type="pmid">38784235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmed.2024.1365524</pub-id><pub-id pub-id-type="pmcid">PMC11111965</pub-id></element-citation></ref><ref id="REF46"><label>46</label><element-citation publication-type="journal"><article-title>Advances in infectious disease vaccine adjuvants</article-title><source>Vaccines (Basel)</source><person-group><name name-style="western"><surname>Fan</surname><given-names>J</given-names></name><name name-style="western"><surname>Jin</surname><given-names>S</given-names></name><name name-style="western"><surname>Gilmartin</surname><given-names>L</given-names></name><name name-style="western"><surname>Toth</surname><given-names>I</given-names></name><name name-style="western"><surname>Hussein</surname><given-names>WM</given-names></name><name name-style="western"><surname>Stephenson</surname><given-names>RJ</given-names></name></person-group><fpage>1120</fpage><volume>10</volume><year>2022</year><pub-id pub-id-type="pmid">35891284</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/vaccines10071120</pub-id><pub-id pub-id-type="pmcid">PMC9316175</pub-id></element-citation></ref><ref id="REF47"><label>47</label><element-citation publication-type="journal"><article-title>Long-term effects of breast cancer therapy and care: calm after the storm?</article-title><source>J Clin Med</source><person-group><name name-style="western"><surname>Tommasi</surname><given-names>C</given-names></name><name name-style="western"><surname>Balsano</surname><given-names>R</given-names></name><name name-style="western"><surname>Corian&#242;</surname><given-names>M</given-names></name><etal/></person-group><fpage>7239</fpage><volume>11</volume><year>2022</year><pub-id pub-id-type="pmid">36498813</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jcm11237239</pub-id><pub-id pub-id-type="pmcid">PMC9738151</pub-id></element-citation></ref><ref id="REF48"><label>48</label><element-citation publication-type="journal"><article-title>Advancements in vaccine adjuvants: the journey from alum to nano formulations</article-title><source>Vaccines (Basel)</source><person-group><name name-style="western"><surname>Moni</surname><given-names>SS</given-names></name><name name-style="western"><surname>Abdelwahab</surname><given-names>SI</given-names></name><name name-style="western"><surname>Jabeen</surname><given-names>A</given-names></name><etal/></person-group><fpage>1704</fpage><volume>11</volume><year>2023</year><pub-id pub-id-type="pmid">38006036</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/vaccines11111704</pub-id><pub-id pub-id-type="pmcid">PMC10674458</pub-id></element-citation></ref><ref id="REF49"><label>49</label><element-citation publication-type="journal"><article-title>Regional anesthesia for geriatric population</article-title><source>Saudi J Anaesth</source><person-group><name name-style="western"><surname>Al Harbi</surname><given-names>MK</given-names></name><name name-style="western"><surname>Alshaghroud</surname><given-names>SM</given-names></name><name name-style="western"><surname>Aljahdali</surname><given-names>MM</given-names></name><name name-style="western"><surname>Ghorab</surname><given-names>FA</given-names></name><name name-style="western"><surname>Baba</surname><given-names>F</given-names></name><name name-style="western"><surname>Al Dosary</surname><given-names>R</given-names></name><name name-style="western"><surname>Bahadeq</surname><given-names>M</given-names></name></person-group><fpage>523</fpage><lpage>532</lpage><volume>17</volume><year>2023</year><pub-id pub-id-type="pmid">37779559</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/sja.sja_424_23</pub-id><pub-id pub-id-type="pmcid">PMC10540989</pub-id></element-citation></ref><ref id="REF50"><label>50</label><element-citation publication-type="journal"><article-title>Vaccine adjuvants: mechanisms and platforms</article-title><source>Signal Transduct Target Ther</source><person-group><name name-style="western"><surname>Zhao</surname><given-names>T</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>X</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tian</surname><given-names>X</given-names></name></person-group><fpage>283</fpage><volume>8</volume><year>2023</year><pub-id pub-id-type="pmid">37468460</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41392-023-01557-7</pub-id><pub-id pub-id-type="pmcid">PMC10356842</pub-id></element-citation></ref><ref id="REF51"><label>51</label><element-citation publication-type="journal"><article-title>Multimodal non-invasive non-pharmacological therapies for chronic pain: mechanisms and progress</article-title><source>BMC Med</source><person-group><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wu</surname><given-names>W</given-names></name></person-group><fpage>372</fpage><volume>21</volume><year>2023</year><pub-id pub-id-type="pmid">37775758</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12916-023-03076-2</pub-id><pub-id pub-id-type="pmcid">PMC10542257</pub-id></element-citation></ref><ref id="REF52"><label>52</label><element-citation publication-type="journal"><article-title>Artificial intelligence and machine learning in pharmacological research: bridging the gap between data and drug discovery</article-title><source>Cureus</source><person-group><name name-style="western"><surname>Singh</surname><given-names>S</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>R</given-names></name><name name-style="western"><surname>Payra</surname><given-names>S</given-names></name><name name-style="western"><surname>Singh</surname><given-names>SK</given-names></name></person-group><fpage>0</fpage><volume>15</volume><year>2023</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.44359</pub-id><pub-id pub-id-type="pmcid">PMC10539991</pub-id><pub-id pub-id-type="pmid">37779744</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>